Outlook Therapeutics Market Sentiment

Outlook Therapeutics Inc

OTLKNASDAQ

Trade with Public

$0.5193

-0.0442-7.84%

마지막 업데이트: Oct 23, 7:38 PM

개요 뉴스 실적 전망 이벤트 목표가 재무심리지분 현황 비교 옵션 주식 보고서

Outlook Therapeutics Market Sentiment - Benzinga

Outlook Therapeutics Market Sentiment

Market sentiment signals for Outlook Therapeutics (OTLK): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▲ 13.9% short float

Options Flow▲ 0.00 P/C ratio

Insider Activity— N/A

Analyst Consensus

Buy

7 analysts

Options Flow (P/C)

0.00

More calls — Bullish

26 calls · 0 puts

Avg Consensus PT

$10

+1737.1%

Highest Price Target

$31

+5847.0%

Brookline Capital

Lowest Price Target

+89.4%

Chardan Capital

Short Interest

13.9%

Declining — Bullish

Insider Activity (30d)

—

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Sep 11, 2026	Ascendiant Capital	Edward Woo—	+1888.6%	$10 → $11	Maintained	Buy
Aug 14, 2026	BTIG	Julian Harrison—	+657.6%	$4 → $4	Maintained	Buy
Jul 27, 2026	HC Wainwright & Co.	Douglas Tsao—	+203.0%	$1 → $2	Maintained	Neutral
Jul 27, 2026	BTIG	Julian Harrison—	+657.6%	$4	Upgrade	Neutral→Buy
Jun 11, 2026	Ascendiant Capital	Edward Woo—	+1793.9%	$6 → $10	Maintained	Buy
May 18, 2026	BTIG	Julian Harrison—	—	—	Downgrade	Buy→Neutral
Mar 11, 2026	Ascendiant Capital	Edward Woo—	+1036.4%	$10 → $6	Maintained	Buy
Feb 18, 2026	HC Wainwright & Co.	Douglas Tsao—	-5.3%	$1 → $1	Maintained	Neutral
Feb 18, 2026	Chardan Capital	Daniil Gataulin—	+89.4%	$1 → $1	Maintained	Neutral
Jan 5, 2026	Chardan Capital	Daniil Gataulin—	+89.4%	$3 → $1	Maintained	Neutral
Jan 2, 2026	HC Wainwright & Co.	Douglas Tsao—	-5.3%	$1 → $1	Maintained	Neutral
Dec 22, 2025	Ascendiant Capital	Edward Woo—	+1793.9%	$8 → $10	Maintained	Buy
Sep 30, 2025	HC Wainwright & Co.	Douglas Tsao—	+89.4%	$1 → $1	Maintained	Neutral
Sep 22, 2025	Ascendiant Capital	Edward Woo—	+1415.2%	$21 → $8	Maintained	Buy
Aug 29, 2025	Guggenheim	Eddie Hickman—	—	—	Downgrade	Buy→Neutral
Aug 29, 2025	HC Wainwright & Co.	Douglas Tsao—	+89.4%	$1	Downgrade	Buy→Neutral
Aug 28, 2025	Chardan Capital	Daniil Gataulin—	+468.2%	$3 → $3	Maintained	Neutral
Aug 15, 2025	Chardan Capital	Daniil Gataulin—	+468.2%	$3 → $3	Maintained	Neutral
Jun 6, 2025	Ascendiant Capital	Edward Woo—	+3877.3%	$24 → $21	Maintained	Buy
Feb 24, 2025	Ascendiant Capital	Edward Woo—	+4445.5%	$33 → $24	Maintained	Buy
Feb 18, 2025	HC Wainwright & Co.	Douglas Tsao—	+468.2%	$30 → $3	Maintained	Buy
Feb 18, 2025	Chardan Capital	Daniil Gataulin—	+468.2%	$3 → $3	Maintained	Neutral
Jan 17, 2025	Guggenheim	Eddie Hickman—	+2172.7%	$12 → $12	Maintained	Buy
Jan 17, 2025	HC Wainwright & Co.	Douglas Tsao—	+5581.8%	$30 → $30	Maintained	Buy
Dec 2, 2024	Chardan Capital	Daniil Gataulin—	—	—	Downgrade	Buy→Neutral